Osteoarthritis affects over 300 million people worldwide. Here, we conduct a genome-wide
association study meta-analysis across 826,690 individuals (177,517 with osteoarthritis) and …

Background Exome sequencing in hundreds of thousands of persons may enable the
identification of rare protein-coding genetic variants associated with protection from human …

Clonal haematopoiesis involves the expansion of certain blood cell lineages and has been
associated with ageing and adverse health outcomes 1 , 2 , 3 , 4 – 5 . Here we use exome …

Obesity traits are causally implicated with risk of cardiometabolic diseases. It remains
unclear whether there are similar causal effects of obesity traits on other non-communicable …

Body fat distribution is a major, heritable risk factor for cardiometabolic disease, independent
of overall adiposity. Using exome-sequencing in 618,375 individuals (including 160,058 …

Few effective therapeutic options are available for the treatment of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. IL-6 receptor blockade has been proposed …

Inhibition of sclerostin is a therapeutic approach to lowering fracture risk in patients with
osteoporosis. However, data from phase 3 randomized controlled trials (RCTs) of romosozumab, …

In this study, we leveraged the combined evidence of rare coding variants and common alleles
to identify therapeutic targets for osteoporosis. We undertook a large-scale multiancestry …

Erectile dysfunction (ED) is a common condition affecting more than 20% of men over 60
years, yet little is known about its genetic architecture. We performed a genome-wide …

Hypersensitivity reactions to drugs are often unpredictable and can be life threatening,
underscoring a need for understanding their underlying mechanisms and risk factors. The extent …